Within the global vaccine market, many variables affect the relationship between pharmaceutical companies and health agencies. Procurement rules, tender specifications, total production capacities, and the number of potential suppliers all impact the price and availability of a given vaccine.
To better understand this complex relationship, Linksbridge created an early-stage simulation model that explores what the pentavalent vaccine market might look like under different scenarios. Drawing on global vaccine market data and transactional histories to inform behavioral assumptions of each agent, the model allows users to adjust common parameters (such as tender period) to see how the market might change over time.
In the future, this simulation model could be used by the global health community to anticipate changing market dynamics and provide better coordination among partners. Additionally, building new supplier strategies could provide even more realistic simulations while reducing global vaccine costs and preventing supply shortages.